Ultragenyx Pharmaceutical(CH:UP0)
CHF 14.92+0.35 (+2.41%)
CH:UP0
Ultragenyx Pharmaceutical earnings date
CHF 14.92
At close:+0.35 (+2.41%)
Ultragenyx Pharmaceutical (UP0) Q3 2025 Earnings Report
0 Followers
CH:UP0 Q3 2025 EPS Results
- Actual EPS
- -CHF 1.53
- Consensus EPS
- -CHF 1.04
- Beat/Miss
- Missed by -CHF 0.49
- One Year Ago EPS
- -CHF 1.18
CH:UP0 Q3 2025 Revenue Results
- Actual Revenue
- CHF 134.93M
- Expected Revenue
- CHF 140.75M
- Beat/Miss
- Missed by -CHF 5.82M
- YoY Revenue Growth
- +14.65%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 11/04/2025
- Time
- After Close
- Conference Call
- Tuesday, November 4, 2025
CH:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q3 2025 Earnings Call Audio
CH:UP0 Q3 2025 Earnings Call
0:00 / 0:00
Q3 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.00- | -1.09 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.93-0.98 | -1.53 | 35.91% (+0.55) | |
| Aug 04, 2026 | 2026 (Q2) | -1.05-0.76 | -0.99 | 23.08% (+0.23) | |
| May 05, 2026 | 2026 (Q1) | -1.26-1.55 | -1.32 | -17.20% (-0.23) | |
| Feb 12, 2026 | 2025 (Q4) | -0.92-1.09 | -1.17 | 7.19% (+0.08) | |
| Nov 04, 2025 | 2025 (Q3) | -1.04-1.53 | -1.18 | -29.29% (-0.35) | |
| Aug 05, 2025 | 2025 (Q2) | -1.09-0.99 | -1.28 | 23.03% (+0.30) | |
| May 06, 2025 | 2025 (Q1) | -1.35-1.32 | -1.71 | 22.66% (+0.39) | |
| Feb 13, 2025 | 2024 (Q4) | -1.10-1.17 | -1.28 | 8.55% (+0.11) | |
| Nov 05, 2024 | 2024 (Q3) | -1.25-1.18 | -1.88 | 37.22% (+0.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

